KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1295 |
|---|---|
| Product Name | Anti-Human IL23A Recombinant Antibody(Tildrakizumab) |
| Molecular Name | Tildrakizumab |
| Alias | Anti-IL23A Recombinant Antibody, Research Grade Tildrakizumab |
| CAS Number | 1326244-10-3 |
| Molecular Weight | 144.4 kDa |
| Target | IL23A[Homo sapiens] |
| Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Host | Mouse |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
| Buffer | PBS, pH7.5 |
| Background | Tildrakizumab (trade name Ilumya (US)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adult patients with moderate-to-severe plaque psoriasis in the United States and the European Union. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
